Cleveland Clinic Study Highlights Value of Electronic Inhaler Monitoring for COPD Patients

June 13, 2019
Sensor provides care team alerts and insights on medication adherence, usage trends

Cleveland Clinic researchers have found that the use of electronic inhaler monitoring, in combination with a disease management program, is associated with reduced healthcare utilization in patients with chronic obstructive pulmonary disease (COPD).

Between October 2016 and May 2017, 39 patients who have COPD and had at least one hospitalization or emergency room visit during the year prior to enrollment took part in the study, led by Amy Attaway, M.D., Umur Hatipoğlu, M.D., Richard Rice, RRT, and Khaled Alshabani. Their paper was published in May in the Journal of Telemedicine and Telecare.

Patients were provided with electronic monitoring devices for maintenance and rescue inhalers for one year. The monitoring platform, provided by Propeller Health, connects a small sensor to a patient’s existing inhaled COPD medication; the sensor then transmits data to the patient’s smartphone, or data hub, delivering alerts and insights on medication adherence and usage trends. Alerts were then emailed to the study team, giving researchers insights on patients’ rescue and controller medication use. (Propeller Health was a Healthcare Innovation Up-and-Coming Company in 2015.)

The results showed a significant reduction in COPD-related healthcare utilization compared to the year prior to enrollment, from an average of 3.4 trips to the hospital to 2.2. There was also a reduction in all-cause healthcare utilization, but that was not statistically significant. 

“We prescribe inhaled medications for patients with COPD all the time. It’s really the cornerstone of their therapy, and when they return to the clinic we do ask them whether they’re using their medications, but the reality is we never know how adherent patients are objectively,” said Dr. Hatipoğlu, a Cleveland Clinic pulmonologist, in a statement. “Electronic inhaler monitoring allows us to assess inhaler adherence at the point of care.”

According the American Lung Association, COPD is the third leading cause of death by disease in the United States. More than 11 million people have been diagnosed with COPD, but millions more may be undiagnosed.  There is currently no cure for COPD.

Sponsored Recommendations

How AI-Native Locating Intelligence Revolutionizes the RTLS market

Discover how leveraging an RTLS solution with artificial intelligence as the location engine can increase efficiency, improve safety, and elevate care without the compromises ...

Harnessing the True Power of Cultural, Clinical and Operational Data

Optimize healthcare performance by combining clinical, operational, and cultural insights. A deeper understanding of team factors improves care and resource management.

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...